Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
BHF Research Could Help Detect Early Signs of Heart Failure in Diabetic Patients
New research that BHF have funded in Leicester could help understand how heart failure can […]
Researchers Investigate New Treatment for Diabetes to Combat Sight Loss
Researchers at the University of Aberdeen are investigating a new treatment for diabetes which they […]
Drug Could Help Hearts Recover After Heart Attack
A drug used to treat certain cancers could improve recovery after a heart attack by […]
AI Breakthrough for Faster, Cheaper and Injection-free Heart Scans
New artificial intelligence (AI) technology could lead to the next generation of heart MRI scans […]
Genes Responsible for High Blood Pressure Discovered in the Human Kidney
Research that the British Heart Foundation part-funded has led to the discovery of 179 kidney […]
Glowing Probe Could Diagnose Cardiovascular Disease Earlier
Researchers have created a probe that glows when it detects an enzyme associated with issues […]
Antiparasitic Drug Could Prevent Coronavirus Lung Damage
A common antiparasitic drug could block lung damage in people with coronavirus, according to new […]
BHF Secure EU Approval for CaRi-Heart®
The first-of-its-kind technology, CaRi-Heart®, was developed by spinout company Caristo Diagnostics and has the power […]
New Clues Point to New 'Silent' Stroke Treatments
Scientists have identified new genetic clues in people who’ve had small and often apparently ‘silent’ […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more